Coronavirus in India: As the number of confirmed coronavirus cases surpassed and death toll reached 109, the Union Health Ministry said that if the Tablighi Jamaat event had not taken place the rate of doubling of COVID-19 cases in India would have been 7.4 days instead of 4.1. Also Read - Delta Plus Variant of Covid-19 in India: 7 Cases Reported From Madhya Pradesh, 2 Deaths
Speaking to media, Joint Secretary of the Health Ministry Lav Agarwal said, “The doubling rate, which means in how many days the number of COVID-19 cases double, at present is 4.1 days. But if cases reported due to the Tablighi Jamaat event had not come, then the doubling rate would have been 7.4 days.” Also Read - Maharashtra Likely To Impose Uniform Restrictions To Control New Delta Plus Variant
States like Tamil Nadu, Delhi, Andhra Pradesh, Telangana, Uttar Pradesh, Rajasthan, Jammu and Kashmir, Assam, Karnataka, Andaman and Nicobar, Uttarakhand, Haryana, Maharashtra, Himachal Pradesh, Kerala, Arunachal Pradesh and Jharkhand have reported corona cases linked to the Tablighi Jamaat. Also Read - IRCTC Latest News: Western Railway to Resume Services of 17 Pairs of Special Trains | Full List Here
Following the controversial religious gathering the total tally of cases in Delhi has left behind the worst-hit Maharashtra and Tamil Nadu. The national capital has 503 cases, while there are 490 cases in Maharashtra, 485 cases in Tamil Nadu.
On the other hand, clarifying whether coronavirus is airborne or not, an ICMR official has said, “We need to understand that in science whoever does experiments some will have a ‘for opinion and some against’ but we need to take a balanced, evidence-based approach.”
“For example, if it was an air-borne infection then in a family whoever has a contact they all should come positive because they are living in same surrounding as the patient and the family is breathing the same air. When someone is admitted in hospital, other patient would have got exposure (if it was air borne) but that is not the case,” said Raman R Gangakhedkar, head of epidemiology and communicable diseases at ICMR.